Soft-Sensor Bioprocessing Patents: Top Companies & Trends 2026
- Concentrated at the top. The ranked leader holds 16 records while the top 5 assignees together account for 54.8% of all 84 records in scope — filing here clusters around a small group of process-control incumbents.
- Growth is real, not flat. Filings rose from 6 in 2021 to 10 in 2024, a 67% increase over that span, even as most named leaders show zero filings in the latest tracked year — a sign of publication lag, not retreat.
- Control-systems framing dominates. G05B (control & regulating systems) touches 77.4% of the 84 records, while C12M (bioreactors) appears in just 9.5% — most soft-sensor validation claims are still written as control engineering, not bioprocess engineering.
Filing growth compares 2021 (6 records) with 2024 (10) — a three-year span. 2024 is the most recent year we treat as complete: publication lags filing by roughly 18 months, so 2025 onwards are still filling in and any growth rate that ends there would understate the field. Top-5 share is the combined record count of the five largest assignees divided by all 84 records in scope (CR5), not by the ranked leaders only.
What this landscape covers
Soft-sensor model validation sits at the junction of process control and machine learning: patents in this set claim ways to estimate a variable that cannot be measured directly — a titer, a concentration, a thermal state — and then prove the estimate is trustworthy using techniques like residual analysis, external validation sets or confidence-interval bounds. The search spans 84 records filed or published between 2015 and mid-2026, tagged against IPC classes covering control systems, AI-based computing and bioreactor apparatus.
Most of the activity traces back to industrial process control — thermal processing, semiconductor fabrication, petroleum refining — rather than biomanufacturing itself. That matters for anyone reading this as a bioprocessing landscape: the validation methods are general-purpose, and the bioreactor-specific claims are a minority slice of a much larger control-engineering corpus.
Filing trends and technology composition
Two views of the same 84 records: how filing activity has moved year over year, and which IPC subclasses the claims actually sit in.
Filing trend, 2017–2026
Filings moved from 3 in 2017 to a peak of 10 in 2024, with 2021's 6 rising to 2024's 10 — a 67% increase over that three-year window. 2025 and 2026 show fewer records, but publication typically lags filing by around 18 months, so the most recent two years are still filling in and should not be read as a slowdown.
Technology composition by IPC subclass
G05B (control & regulating systems) appears in 77.4% of the 84 records and G06N (AI-based computing) in 42.9%, confirming that most claims frame the soft sensor as a control-loop component with a learned model inside it. Bioreactor-specific apparatus (C12M) reaches only 9.5% of records, and material analysis and testing (G01N) 10.7% — narrower, more biology-specific claim territory that the broader control-systems filings largely bypass.
Shares are the percentage of the 84 records in scope. A patent can carry several IPC classes, so the shares add up to more than 100%.
Go deeper on Soft-Sensor Bioprocessing Model Validation with Eureka
This page is one run against one query. Ask Eureka your own question about soft-sensor bioprocessing model validation and every answer comes back with the patent numbers behind it.
Try EurekaRepresentative and most-cited filings
US11078428B2 — Generating a soft sensor for crude stabilization in the petroleum industry
A global theoretical graphical representation of a soft sensor is generated based on a cursory model, where the soft sensor is used to control crude stabilization. A plurality of local real-life graphical representations are generated for the soft sensor, each corresponding to a respective local regime. A global real-life graphical representation is generated by combining the local representations, and a set of numerical values for the soft sensor is generated from it. The soft sensor is updated based on lab results and a crude stabilization outcome.Filed by Saudi Arabian Oil Company, published 2021-08-03 — illustrates how validation-against-lab-results claims get written outside the biomanufacturing sector proper.
| # | Publication no. | Patent title | Citations |
|---|---|---|---|
| 1 | US6207936B1 | Model-based predictive control of thermal processing | 579 |
| 2 | US20090198350A1 | Robust adaptive model predictive controller with tuning to compensate for model mismatch | 291 |
| 3 | US6373033B1 | Model-based predictive control of thermal processing | 184 |
| 4 | US20180262525A1 | Multi-modal, multi-disciplinary feature discovery to detect cyber threats in electric power grid | 140 |
| 5 | US6760716B1 | Adaptive predictive model in a process control system | 115 |
| 6 | US20040098145A1 | Hybrid cascade model-based predictive control system | 86 |
| 7 | US20120221124A1 | Using autocorrelation to detect model mismatch in a process controller | 36 |
| 8 | US7006900B2 | Hybrid cascade model-based predictive control system | 35 |
| 9 | US20170269559A1 | System and Method for Online Measurement of Vapor Pressure in Hydrocarbon Process Streams | 34 |
| 10 | US20220198333A1 | Recipe optimization through machine learning | 21 |
Citation counts accumulate over time, so older control-systems patents dominate this list even where newer bioprocessing-specific filings are more relevant to current work. Treat citation rank as a signal of influence within the corpus, not of present-day importance.
Each row carries its publication number; clicking a row searches Eureka by that number.
Put your own technology through the same analysis
Eureka on the web
When you want the answer in the next five minutes.
The agent works the prompt against patents and technical literature, citing every source.
Run your analysis now →MCP server & REST API
When it has to run inside your own pipeline.
Patent search, landscape analysis and assignee resolution as MCP tools. Drop them into any agent framework, or call REST directly.
Browse MCP servers →What the numbers mean for filing strategy
Three patterns stand out once family-level concentration, filing pace and technology mix are read together.
A small group sets the claim boundaries
The top 5 assignees together hold 54.8% of all 84 records, and the top 10 reach 73.8%. A field this concentrated means new entrants are filing around, not into, well-mapped claim territory — freedom-to-operate work should start with the leader's portfolio, not a broad novelty search.
Growth is recent and still under-reported
Filings climbed from 6 in 2021 to 10 in 2024. Several of the most active named assignees show zero filings in the latest tracked year, which reads as a warning sign only if you ignore the roughly 18-month gap between filing and publication — recent-year figures are provisional by construction.
Control engineering, not bioprocess engineering, sets the vocabulary
G05B classification touches 77.4% of records versus 9.5% for bioreactor-specific C12M. Drafting a soft-sensor validation claim that reads onto bioprocessing specifically, rather than onto generic control-loop language, is where most of the open space in this set actually sits.
Eureka can read the same corpus for gaps instead of for coverage: under-claimed branches adjacent to soft-sensor bioprocessing model validation, with the prior art for and against each one.
Who holds the ground, and where the gate sits
Filing activity concentrates among industrial process-control and instrumentation companies with petroleum, semiconductor and automation backgrounds — bioprocessing-native filers are a minority even where their claims are the most directly relevant.
A single instrumentation incumbent sets the pace
The ranked leader holds 16 of the 84 records — nearly a fifth of the entire field on its own — reflecting decades of process-control patenting that predates the current soft-sensor terminology.
Most filers appear once or twice
Beyond the top 10, which already covers 73.8% of records, the remaining ranked assignees each hold a small handful of filings. That long tail includes bioprocessing-adjacent names alongside oil, semiconductor and grid-security filers pulled in by shared control-systems language.
Recent-year activity looks quiet — read that with care
Multiple leading assignees, including two with -100% year-on-year figures, show no filings in the latest tracked year. Given the roughly 18-month publication lag, this is most likely a reporting gap rather than a genuine pullback from the space.
| Assignee | Recent year | YoY |
|---|---|---|
| Fisher-Rosemount Systems, Inc. | 0 | — |
| Applied Materials, Inc. | 0 | -100% |
| Institutt for Energiteknikk (Institute for Energy Technology) | 0 | — |
| ASM America, Inc. | 0 | — |
| Sartorius Stedim Data Analytics AB | 0 | -100% |
| Rockwell Automation Technologies, Inc. | 0 | — |
| General Electric Company | 0 | — |
| Saudi Arabian Oil Company | 0 | — |
Where to take this landscape
The dataset points to a field where the claim language is set by process-control incumbents, but the fastest-growing filing activity is recent enough that the picture is still forming.
Map freedom-to-operate against the top 5
With 54.8% of records held by five assignees, a targeted claim-chart review of their families is more useful than a broad landscape scan before committing to a drafting direction.
Run a freedom-to-operate check in EurekaWatch the 2024–2026 filings as they resolve
Because publication lags filing by about 18 months, the true 2025–2026 filing count will only become visible over the next reporting cycles — worth revisiting rather than treating the current dip as fact.
Set a monitoring alert in EurekaDraft toward the bioreactor-specific gap
C12M and G06Q classifications remain thin relative to the control-systems core, suggesting room for claims that tie soft-sensor validation explicitly to bioprocess variables and outputs.
Explore white space in EurekaCommon questions about this landscape
A soft sensor, sometimes called a virtual or inferential sensor, is a model-based estimate of a process variable that is not measured directly by a physical instrument — for example inferring a metabolite concentration from temperature, pH and flow readings. In this dataset the term is used broadly, covering thermal processing, semiconductor fabrication and petroleum refining as well as bioprocessing, because the underlying validation methods are shared across industries. Patent claims typically combine the estimation model itself with a validation step, such as an external validation set or a residual-analysis check, that proves the estimate is reliable enough to act on.
Filing is concentrated: the ranked leader alone holds 16 of the 84 records in scope, and the top 5 assignees together account for 54.8% of all records. The leaders are drawn mostly from industrial process-control and instrumentation backgrounds rather than biomanufacturing specifically, reflecting the field's roots in thermal and chemical process control. Beyond the top 10 filers, who together cover 73.8% of records, the remaining ranked assignees each hold only a handful of filings.
Filings grew from 6 in 2021 to a peak of 10 in 2024, a 67% increase over that three-year span, which is genuine growth rather than noise. The apparent drop in 2025 and 2026 should not be read as a slowdown: patent publication typically lags filing by around 18 months, so the most recent one to two years are still incomplete in any dataset. The 2024 figure is the most recent year that can be treated as a complete picture of filing activity.
Less than a third, based on IPC composition. Control and regulating systems (G05B) appear in 77.4% of the 84 records and AI-based computing (G06N) in 42.9%, while bioreactor-specific apparatus (C12M) appears in only 9.5%. That means most of the claim language in this landscape was written for control-loop or machine-learning contexts generally, and bioprocessing-specific soft-sensor claims are a comparatively thin, and potentially more open, slice of the field.
The clearest gap sits where bioreactor-specific apparatus claims (C12M, 9.5% of records) intersect with validation techniques like external validation sets, residual analysis or confidence-interval reporting — a combination that is common in general process control but thin when tied explicitly to fermentation or continuous bioprocessing variables. Business-process integration of soft-sensor outputs (G06Q, 7.1% of records) is another under-filed adjacency. Anyone drafting into this space should check the top assignees' existing families first, since the field's concentration means broad control-systems language is already well covered.
Research Soft-Sensor Bioprocessing Model Validation in depth with Eureka
Go past this page: query the whole soft-sensor bioprocessing model validation corpus yourself, in your own scope.
Every answer comes back with patent numbers you can open.
Disclaimer. This page is generated from Patsnap Eureka data drawn from a limited snapshot of global patent and scientific-literature records, and is provided for general information and reference only.
Patent data carries inherent limitations: recent filings (typically the most recent 18–24 months) are under-counted due to standard publication lag; counts may be reported at either a patent-family or a patent-record basis and are not always directly comparable; classification, applicant-name, and citation data may contain errors, duplicates, or omissions; and the underlying search query defines and constrains the scope shown. As a result, the analysis may be incomplete or inaccurate and may not reflect the full technology landscape.
Nothing on this page constitutes an exhaustive prior-art, novelty, freedom-to-operate, or validity search, nor does it constitute legal, financial, investment, or professional advice, and it should not be relied upon as such. Any patent, commercial, or strategic decision should be verified independently and reviewed with qualified patent, legal, and domain professionals. Patsnap makes no warranties, express or implied, as to the accuracy, completeness, or fitness for any particular purpose of the information presented.
Machine translation. Assignee and organisation names originally recorded in Chinese, Japanese or Korean have been rendered into English by an AI translation step so that the tables stay readable. These renderings are best-effort and may not match a company’s registered English name; the original name is what the underlying patent record carries, and it is what any Eureka query launched from this page uses.